Durable LVAD Therapy in End-Stage Methamphetamine-Associated Heart Failure: A Case Report of the Bridge to Opportunity and Transplant Candidacy

Clicks: 1
ID: 320889
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #40 of 248 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 248 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Methamphetamine-associated heart failure (MAHF) is an increasingly recognized cause of severe non-ischemic cardiomyopathy with a 231% rise in hospital admissions from 2008 to 2020. MAHF is associated with high morbidity and mortality, and advanced therapies options are challenged by substance use and addiction. Case A 40-year-old male with advanced MAHF and active substance use presented with out-of-hospital cardiac arrest requiring escalating temporary mechanical circulatory support and ultimately durable left ventricular assist device (LVAD) placement as a bridge to candidacy strategy. After six months of documented abstinence from substances and engagement in outpatient addiction medicine treatment his Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) score had improved from 53 to 23, reclassifying him from a “poor” to “minimally acceptable” transplant candidate. He underwent successful cardiac transplantation and continues to be abstinent at twenty-one months post transplantation. Discussion This case demonstrates that active substance use represents a modifiable rather than absolute barrier to cardiac transplantation when addressed through a structured multidisciplinary framework, the bridge to opportunity. In the bridge to opportunity, durable LVAD implantation allowed for the hemodynamic support for a patient with end-stage methamphetamine-associated heart failure (MAHF) to engage in outpatient addition medicine care and demonstrate sustained sobriety. Ethical concerns regarding equitable organ allocation are best addressed through individualized psychosocial risk stratification using validated tools such as the SIPAT, rather than categorical exclusion of patients with substance use disorders. The bridge to opportunity is a reproducible model for appropriately resourced multidisciplinary transplant programs and appropriately selected patients.
Reference Key
openalex_W7168142006 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Cooper B. Kersey, Jennifer Lynn Azen, Lisa Wiederspan, Sunny Rockom, Jennifer A. Beckman, Salpy V. Pamboukian, Sunu S. Thomas
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag498
URL
https://doi.org/10.1093/ehjcr/ytag498
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.